Cargando…
Interstitial lung disease is not rare in immune-mediated necrotizing myopathy with anti-signal recognition particle antibodies
OBJECTIVES: The purpose was to clarify the characteristics of interstitial lung disease (ILD) in immune-mediated necrotizing myopathy (IMNM) patients with anti-signal recognition particle (SRP) antibodies. METHODS: Medical records of IMNM patients with anti-SRP antibodies were reviewed retrospective...
Autores principales: | Ge, Yongpeng, Yang, Hanbo, Xiao, Xinyue, Liang, Lin, Lu, Xin, Wang, Guochun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8744320/ https://www.ncbi.nlm.nih.gov/pubmed/35000598 http://dx.doi.org/10.1186/s12890-021-01802-1 |
Ejemplares similares
-
Development of Necrotizing Myopathy Following Interstitial Lung Disease with Anti-signal Recognition Particle Antibody
por: Kusumoto, Tatsuya, et al.
Publicado: (2018) -
Clinical characteristics of myositis patients with isolated anti-U1 ribonucleoprotein antibody resemble immune-mediated necrotizing myopathy
por: Ge, Yongpeng, et al.
Publicado: (2023) -
Factors associated with refractory autoimmune necrotizing myopathy with anti-signal recognition particle antibodies
por: Zhao, Yawen, et al.
Publicado: (2020) -
Anti-signal Recognition Particle Necrotizing Autoimmune Myopathy: An Atypical Presentation
por: Khan, Muhammad H, et al.
Publicado: (2018) -
Clinical Characteristics of Anti-3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Antibodies in Chinese Patients with Idiopathic Inflammatory Myopathies
por: Ge, Yongpeng, et al.
Publicado: (2015)